These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12064297)

  • 1. HIV and hepatitis C. Lab tests you should know about.
    WORLD; 2002 May; (133):3. PubMed ID: 12064297
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biotechnology applied to the diagnosis of HIV/hepatitis C co-infection].
    Maroto Vela MC
    An R Acad Nac Med (Madr); 1996; 113(3):643-55; discussion 655-8. PubMed ID: 9124648
    [No Abstract]   [Full Text] [Related]  

  • 3. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GB virus C genotype 2 predominance in a hepatitis C virus/HIV infected population associated with reduced liver disease.
    Berzsenyi MD; Bowden DS; Roberts SK; Revill PA
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1407-10. PubMed ID: 19702909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of patients with hepatitis C virus infection. Virological tests].
    Pawlotsky JM
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B180-7. PubMed ID: 12180286
    [No Abstract]   [Full Text] [Related]  

  • 6. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown.
    Castillo I; Pardo M; Bartolomé J; Ortiz-Movilla N; Rodríguez-Iñigo E; de Lucas S; Salas C; Jiménez-Heffernan JA; Pérez-Mota A; Graus J; López-Alcorocho JM; Carreño V
    J Infect Dis; 2004 Jan; 189(1):7-14. PubMed ID: 14702147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in European HIV-infected patients with anti-HCV antibodies.
    Pascual Pareja JF; Montes ML; González-García J; Arribas JR
    J Infect Dis; 2009 May; 199(10):1556-7; author reply 1557. PubMed ID: 19392631
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of causes for liver function deterioration in patients with HIV/HCV co-infection.
    Zhang YH; Chen XY; Jiang Y; Xiao Y; Liu Z; Long XS; Wu H
    Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):538-42. PubMed ID: 15567741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical aspects and diagnosis of hepatitis C].
    Leifeld L; Spengler U; Sauerbruch T
    Dtsch Med Wochenschr; 2000 Dec; 125(48):1471-4. PubMed ID: 11153417
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of hepatitis C virus (HCV) in serum and peripheral-blood mononuclear cells from HCV-monoinfected and HIV/HCV-coinfected persons.
    Blackard JT; Smeaton L; Hiasa Y; Horiike N; Onji M; Jamieson DJ; Rodriguez I; Mayer KH; Chung RT
    J Infect Dis; 2005 Jul; 192(2):258-65. PubMed ID: 15962220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease.
    Yoo TW; Donfield S; Lail A; Lynn HS; Daar ES;
    J Infect Dis; 2005 Jan; 191(1):4-10. PubMed ID: 15592996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C: a hepatologist's approach to an infectious disease.
    Rosenberg PM
    Clin Infect Dis; 2001 Nov; 33(10):1728-32. PubMed ID: 11595980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver toxicities rising.
    Pieribone D
    Posit Living; 2000 Aug; 9(7):19, 23. PubMed ID: 12492029
    [No Abstract]   [Full Text] [Related]  

  • 14. The challenge of hepatitis C and HIV co-infection.
    Carriero DC; Lucas J; Freemantle H; Dieterich DT
    Body Posit; 2005; 18(1):8-12, 15-7. PubMed ID: 16193566
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rapid seroreversion following spontaneous recovery of acute hepatitis C in an HIV infected patient].
    Vaghefi P; Roque-Afonso AM; Dussaix E
    Pathol Biol (Paris); 2006 Jul; 54(6):347-8. PubMed ID: 16530353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focus on hepatitis. Final APRICOT, ACTG A5071 results.
    Highleyman L
    IAPAC Mon; 2004 Sep; 10(9):356-7. PubMed ID: 15801102
    [No Abstract]   [Full Text] [Related]  

  • 17. Living with HIV and hepatitis C.
    Hull B
    WORLD; 2002 May; (133):1. PubMed ID: 12064294
    [No Abstract]   [Full Text] [Related]  

  • 18. Strategies for managing hepatitis C virus infection in HIV-infected patients.
    Clanon KA
    Top HIV Med; 2003; 11(2):50-4. PubMed ID: 12717042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection.
    ; McCaughan GW; Omata M; Amarapurkar D; Bowden S; Chow WC; Chutaputti A; Dore G; Gane E; Guan R; Hamid SS; Hardikar W; Hui CK; Jafri W; Jia JD; Lai MY; Wei L; Leung N; Piratvisuth T; Sarin S; Sollano J; Tateishi R
    J Gastroenterol Hepatol; 2007 May; 22(5):615-33. PubMed ID: 17444847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.